课题基金 / 基金详情

Do HIV-infected Alveolar Macrophages represent a cART-resistant Reservoir?

Do HIV-infected Alveolar Macrophages represent a cART-resistant Reservoir?
HIV 感染的肺泡巨噬细胞是否代表 cART 耐药性储库?
批准号:
9306347
负责人:
DAVID G RUSSELL
金额:
$46.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-15 至 2017-07-31

项目摘要

项目成果

DAVID G RUSSELL的其他基金

相似基金

相关文献

中文摘要
翻译

英文摘要
 DESCRIPTION (provided by applicant): Although it is widely accepted that resting, latently-infected CD4+ T-cells are a cART-resistant reservoir for HIV, little attention has been devoted to alternative reservoir sites. Using an ultrasensitive Fluorescent in situ Hybridization (FISH)-based system for detecting HIV mRNA by flow cytometry we mapped the distribution of HIV in the lung of chronically infected, asymptomatic HIV-seropositive individuals and found the virus to be present at greater abundance in alveolar macrophages (AMs) than in lymphocytes. AMs are unusual in that they are long-lived cells derived from a self-sustaining cell lineage retained within the lung. Recently, we extended our study to a cohort of patients on cART and found that those AMs positive for HIV mRNA persisted at sustained levels despite some individuals having been on cART for up to 9 years. The goal of this proposal is to assess the significance of these HIV-positive AMs as a potential reservoir with the capacity to reconstitute peripheral viremia upon cessation or failure of cART, and to develop strategies for its eradication. 1. Molecular Characterization of HIV-infected AMs. We have modified our FISH detection platform to sort cells positive for HIV mRNA, enabling us to perform RNASeq to profile both host and viral transcriptomes, and DeepSeq analysis of viral genome insertion sites to map viral population structure. We propose defining the viral genomes from individuals on suppressive cART to compare with peripheral virus isolated from those individuals who subsequently go on to fail therapy to establish their relatedness. 2. Are HIV mRNA-positive AMs productively infected? We will determine whether HIV mRNA-positive AMs can generate infectious virions that could seed CD4+ T-cells and reconstitute viremia. We are re-engineering viral reporter cell lines for use in Malawi to detect production of infectious virions from infected AMs. 3. Are AMs in non-human primates (NHP) similarly infected with SIV? Our collaborators, Dr. Charles Scanga, University of Pittsburgh and Dr. Shelby O'Connor, University of Wisconsin, are conducting a NHP study of SIV/M.tb co-infection. We will analyze these macaques during early SIV infection to determine whether NHP infected with SIV exhibit efficient early seeding of the AM population. We will also perform FISH and RNASeq on these cells to compare with the human HIV transcriptomes. 4. Can HIV-positive AMs be driven to cell death in vitro? We will pursue novel strategies towards elimination of these cells. The critical difference between CD4+ T-cells and macrophages is that macrophages are not driven to cell death by the infection. We will manipulate in vitro-infected human monocyte-derived macrophages (HMDMs) and AMs by chemical perturbation to generate preliminary data for a future HTS for small molecules capable of driving HIV-infected AMs into programmed cell death.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of epigenetic programming of tissue resident macrophage lineages to impact HIV-1 infection, maintenance, and persistence.
  • 批准号:
    10675934
  • 项目类别:
  • 资助金额:
    $69.52万
  • 财政年份:
    2023
  • 负责人:
    DAVID G RUSSELL
  • 依托单位:
BSL3 Flow Sorter for Human Pathogens of Global Significance
  • 批准号:
    10412511
  • 项目类别:
  • 资助金额:
    $36.23万
  • 财政年份:
    2022
  • 负责人:
    DAVID G RUSSELL
  • 依托单位:
Minimizing in vivo Drug Tolerance induction in tuberculosis.
Minimizing in vivo Drug Tolerance induction in tuberculosis.
  • 批准号:
    10271650
  • 项目类别:
  • 资助金额:
    $60.81万
  • 财政年份:
    2021
  • 负责人:
    DAVID G RUSSELL
  • 依托单位:
海外基金